Innovation Pharmaceuticals Inc (IPIX)

[olden_grumpini]

I don't see any upside to the 60 day phone call.

The best you can hope for is that it confirms what they knew at Day 29: No lingering side effects from brilacidin.

The only data it can add is NEGATIVE . . . that the subjects who received brilacidin are experiencing lingering side effects.

We already know what remdesivir does since it's been administered to hundreds of thousands if not millions of subjects.

Seems pretty straightforward to me.